Comments to U.S. Trade Representative: China Share page: Docket Number: USTR-2018-0005 CHPA is pleased to provide comments on behalf of our members in response to the notice regarding the “acts, policies, and practices of China determined to be unreasonable or discriminatory and to burden or restrict U.S. commerce.” Download Document Issues: OTC Medicines Related Posts Press Releases and Statements Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low According to NIDA Survey Dec 18, 2024 Pediatric Cough/Cold Dosing Press Releases and Statements CHPA Joins U.S. Senators Grassley & Coons at Anti-Counterfeiting Event Dec 13, 2024